AR and adenocarcinoma: Studies in GEMMs of PCa [4–6] have evidenced both AR heterogeneity and lineage plasticity that accompany development and progression from adenocarcinoma to NEPC driven by (co-)deletion of tumor suppressor genes Pten, Rb1 and/or p53 (Figure 4A).